• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Hospira

Hospira

Western Asset Core Bond FI WAPIX 4 Star

Last Price$12.25Day Change (%)0.16%
Open Price$12.25Day Change ($)0.02
Day Range12.25–12.2552-Week Range12.12–12.56

As of Thu 02/10/2016 | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Pfizer Commends The FDA Advisory Committee’s Vote To Approve Proposed Biosimilar Infliximab, The First Biosimilar Monoclonal Antibody Reviewed, For All Eligible Indications

    Pfizer Commends The FDA Advisory Committee’s Vote To Approve Proposed Biosimilar Infliximab, The First Biosimilar Monoclonal Antibody Reviewed, For All Eligible Indications

  2. Pfizer Beats Expectations, but Guidance Disappoints -- 2nd Update

    Pfizer Beats Expectations, but Guidance Disappoints -- 2nd Update

  3. Global Cardiovascular Partnering Deal Trends, Players and Financials 2010-2016 - Research and Markets

    Global Cardiovascular Partnering Deal Trends, Players and Financials 2010-2016 - Research and Markets

  4. UPDATE: Pfizer beats profit expectations, but provides downbeat outlook

    UPDATE: Pfizer beats profit expectations, but provides downbeat outlook

  5. Global Medical Device Packaging Market 2016-2020 - Demand for High-Barrier Films Increasing in the U.S. - Research and Markets

    Global Medical Device Packaging Market 2016-2020 - Demand for High-Barrier Films Increasing in the U.S. - Research and Markets

  6. Novartis Profit Dives 57% on Eye-Care Woes --2nd Update

    Novartis Profit Dives 57% on Eye-Care Woes --2nd Update

  7. Drug Delivery Market Analysis - Forecast (2015-2020) - Prominent Players are 3M, Abbott Laboratories, Thermo Fischer Scientific, Medtronics, Roche & Baxter - Research and Markets

    Drug Delivery Market Analysis - Forecast (2015-2020) - Prominent Players are 3M, Abbott Laboratories, Thermo Fischer Scientific, Medtronics, Roche & Baxter - Research and Markets

  8. United States Pharmaceutical Preparation Market 2015 - Analysis And Forecast to 2020 - Research and Markets

    United States Pharmaceutical Preparation Market 2015 - Analysis And Forecast to 2020 - Research and Markets

  9. Pfizer's Acquisition of Hospira Strengthens Its Moat at a Fair Price

    Despite the high 39% premium to Hospira's stock price, we believe the acquisition price is justified based on Pfizer's ability to unlock more value with its global reach.

  10. Hospira HSP Q1 2014 Earnings Call Transcript

    Welcome to Hospira's First Quarter 2014 Conference Call. All lines have been placed on listen-only mode to prevent any background noise. Following the speakers' remarks, there will be a question-and-answer period.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.